Catch It While You Can: Smaller Firms Flock To China As Value Takes Center Stage

Quality Focus, Trade War To Spur Intra-Asian Deals?

25 Nov 2019

Widely viewed as the largest fast-growing pharma market, China can nevertheless be hard to crack for small to mid-sized companies. But a new policy emphasis on quality and affordability are providing a rare opening for those with the right product mix and local partnerships in hand.

China growth — Japan Generic Firms Eye China Opportunities • Source: Shutterstock

As China rolls out a massive centralized procurement program to slash prices for many widely-used off-patented drugs, some are seeing market opportunities.

Up to now, the generic drug sector in the country - which accounts for over 70% of the world’s second-largest...